On May 9, 2026, DigiAsia Corp. signed a deal to sell its subsidiary, DigiAsia Bios, to PayMate India, potentially leading to DigiAsia holding 49% of PayMate's shares. The transaction involves two closings, with several conditions to be met for finalization.